1 MARKET INTRODUCTION 1.1. Market Definitions 1.2. Objective of the Study 1.3. Limitation 1.4. Stake Holders 1.5. Currency Used in Report 1.6. Scope of the Global Liquid Biopsy Market Study 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1. Research Methodology for the Global Liquid Biopsy Market 2.1.1. Main Objective of the Global Liquid Biopsy Market 3 MARKET SYNOPSIS 4 EXECUTIVE SUMMARY 5 COVID-19 IMPACT 6 GLOBAL LIQUID BIOPSY MARKET REVENUE 7 MARKET INSIGHTS BY TYPE 7.1. Lung 7.2. Breast 7.3. Colorectal 7.4. Prostate 8 MARKET INSIGHTS BY CIRCULATING BIOMARKERS 8.1. Circulating Tumor Cells 8.2. Circulating Tumor DNA 8.3. Cell-Free DNA 9 MARKET INSIGHTS BY PRODUCT 9.1. Instruments 9.2. Assay Kits 10 MARKET INSIGHTS BY END USER 10.1. Reference Laboratories 10.2. Hospitals and Physician Laboratories 10.3. Academic and Research Centers 11 MARKET INSIGHTS BY REGION 11.1. North America Liquid Biopsy Market 11.1.1. United States 11.1.2. Canada 11.1.3. Rest of North America 11.2. Europe Liquid Biopsy Market 11.2.1. Germany 11.2.2. France 11.2.3. U.K. 11.2.4. Spain 11.2.5. Italy 11.2.6. Rest of Europe 11.3. Asia Pacific Liquid Biopsy Market 11.3.1. China 11.3.2. Japan 11.3.3. India 11.3.4. Australia 11.3.5. Rest of Asia Pacific 11.4. Rest of the World Liquid Biopsy Market 12 LIQUID BIOPSY MARKET DYNAMICS 12.1. Market Drivers 12.2. Market Challenges 12.3. Impact Analysis 13 LEGAL & REGULATORY FRAMEWORK 14 DEMAND AND SUPPLY SIDE ANALYSIS 14.1. Demand Side Analysis 14.2. Supply Side Analysis 14.2.1. Top Product Launches 14.2.2. Top Business Partnerships 14.2.3. Top Merger & Acquisitions 15 VALUE CHAIN ANALYSIS 16 LIQUID BIOPSY MARKET OPPORTUNITIES 17 LIQUID BIOPSY MARKET TRENDS & INSIGHTS 18 COMPETITIVE SCENARIO 18.1. Porter’s Five forces analysis 18.1.1. Bargaining power of Supplier 18.1.2. Bargaining power of Buyer 18.1.3. Industry Rivalry 18.1.4. Availability of Substitute 18.1.5. Threat of new Entrants 19 COMPANY PROFILED 19.1. Thermo Fisher Scientific, Inc. 19.1.1. Key Facts 19.1.2. Business Description 19.1.3. Key Product/Services Offerings 19.1.4. Growth Strategy 19.1.5. SWOT Analysis 19.1.6. Key Financials 19.1.6.1. Revenue Split 19.1.6.2. Financial Overview of Thermo Fisher Scientific, Inc. 19.1.7. Recent Developments 19.1.7.1. Product Launch 19.1.7.2. Partnerships 19.1.7.3. Business Expansion and Investments 19.1.7.4. Merger and Acquisition 19.2. Roche Diagnostics 19.3. Biocept, Inc 19.4. Thermo Fisher Scientific Inc 19.5. Qiagen N.V. 19.6. Bio-Rad Laboratories, Inc 19.7. Menarini-Silicon Biosystems 19.8. Illumina, Inc 19.9. MDXhealth SA 19.10. Genomic Health, Inc 20 DISCLAIMER

Roche Diagnostics, Biocept, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Menarini-Silicon Biosystems, Illumina, Inc., MDXhealth SA, Genomic Health, Inc., Guardant Health Inc.